128 related articles for article (PubMed ID: 11103892)
1. Housing conditions and the anxiolytic efficacy of buspirone: the relationship between main and side effects.
Haller J; Halász J; Makara GB
Behav Pharmacol; 2000 Aug; 11(5):403-12. PubMed ID: 11103892
[TBL] [Abstract][Full Text] [Related]
2. The effect of social factors on the anxiolytic efficacy of buspirone in male rats, male mice, and men.
Majercsik E; Haller J; Leveleki C; Baranyi J; Halász J; Rodgers RJ
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Dec; 27(8):1187-99. PubMed ID: 14659474
[TBL] [Abstract][Full Text] [Related]
3. The effect of glucocorticoids on the anxiolytic efficacy of buspirone.
Haller J; Leveleki C; Halász J; Baranyi J; Makara GB
Psychopharmacology (Berl); 2001 Oct; 157(4):388-94. PubMed ID: 11605098
[TBL] [Abstract][Full Text] [Related]
4. Social instability in female rats: effects on anxiety and buspirone efficacy.
Haller J; Baranyi J; Bakos N; Halász J
Psychopharmacology (Berl); 2004 Jul; 174(2):197-202. PubMed ID: 14760513
[TBL] [Abstract][Full Text] [Related]
5. The effects of buspirone on the behaviour of control and stressed mice.
Pokk P; Zharkovsky A
J Physiol Pharmacol; 1998 Mar; 49(1):175-85. PubMed ID: 9594420
[TBL] [Abstract][Full Text] [Related]
6. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
[TBL] [Abstract][Full Text] [Related]
7. The phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze test is abolished by previous administration of chlordiazepoxide or buspirone.
Escarabajal MD; Torres C; Flaherty CF
Life Sci; 2003 Jul; 73(8):1063-74. PubMed ID: 12818358
[TBL] [Abstract][Full Text] [Related]
8. Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats.
Fernández-Guasti A; Reyes R; Martínez-Mota L; López-Muñoz FJ
Psychopharmacology (Berl); 2005 Jul; 180(3):399-407. PubMed ID: 15719217
[TBL] [Abstract][Full Text] [Related]
9. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
[TBL] [Abstract][Full Text] [Related]
10. Diazepam, but not buspirone, induces similar anxiolytic-like actions in lactating and ovariectomized Wistar rats.
Fernández-Guasti A; Ferreira A; Picazo O
Pharmacol Biochem Behav; 2001 Sep; 70(1):85-93. PubMed ID: 11566145
[TBL] [Abstract][Full Text] [Related]
11. Dose dependent effects of serotonergic agents on anxiety.
Kolcsar M; Gáll Z; Dogaru MT
Acta Physiol Hung; 2014 Dec; 101(4):479-87. PubMed ID: 25532957
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone.
Koenig JI; Meltzer HY; Gudelsky GA
Pharmacol Biochem Behav; 1988 Apr; 29(4):711-5. PubMed ID: 2901112
[TBL] [Abstract][Full Text] [Related]
13. The pituitary-adrenal axis and the different behavioral effects of buspirone and chlordiazepoxide.
McNaughton N; Panickar KS; Logan B
Pharmacol Biochem Behav; 1996 May; 54(1):51-6. PubMed ID: 8728538
[TBL] [Abstract][Full Text] [Related]
14. Anxiolytic effects of the novel anti-epileptic drug levetiracetam in the elevated plus-maze test in the rat.
Gower AJ; Falter U; Lamberty Y
Eur J Pharmacol; 2003 Nov; 481(1):67-74. PubMed ID: 14637176
[TBL] [Abstract][Full Text] [Related]
15. Anxiolytic-like activity of the mGluR5 antagonist MPEP: a comparison with diazepam and buspirone.
Brodkin J; Busse C; Sukoff SJ; Varney MA
Pharmacol Biochem Behav; 2002 Sep; 73(2):359-66. PubMed ID: 12117590
[TBL] [Abstract][Full Text] [Related]
16. A possible mechanism for the anxiolytic-like effect of gallic acid in the rat elevated plus maze.
Mansouri MT; Soltani M; Naghizadeh B; Farbood Y; Mashak A; Sarkaki A
Pharmacol Biochem Behav; 2014 Feb; 117():40-6. PubMed ID: 24345572
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.
Griebel G; Perrault G; Sanger DJ
Psychopharmacology (Berl); 1998 Jul; 138(1):55-66. PubMed ID: 9694527
[TBL] [Abstract][Full Text] [Related]
18. Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze.
Wada T; Fukuda N
Psychopharmacology (Berl); 1991; 104(4):444-50. PubMed ID: 1685794
[TBL] [Abstract][Full Text] [Related]
19. Performance in anxiety and spatial memory tests following bilateral vestibular loss in the rat and effects of anxiolytic and anxiogenic drugs.
Zheng Y; Cheung I; Smith PF
Behav Brain Res; 2012 Nov; 235(1):21-9. PubMed ID: 22824589
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.
Pellow S; File SE
Pharmacol Biochem Behav; 1986 Mar; 24(3):525-9. PubMed ID: 2871560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
